The Latest
-
Why this ASX biotech stock is soaring 30% today
-
Another CSL blow: Why this beaten-up ASX giant is sliding again
-
This ASX gold company’s aggressive M&A program continues with $300 million deal
-
Leading brokers name 3 ASX shares to buy today